No Data
No Data
Wells Fargo Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $112
Procept BioRobotics Resumed With an Overweight at Wells Fargo
Procept Biorobotics Insider Sold Shares Worth $2,584,638, According to a Recent SEC Filing
Insider Sale: President of $PRCT (PRCT) Sells 18,144 Shares
Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
No Data
Yolo_tdm : thank u
Stock_Drift OP Yolo_tdm : YW. Appreciate it.
105711459 : Appreciate it, crazy performance by $Healthcare Triangle (HCTI.US)$
Boxman Stock_Drift OP : Nice volume here
Stock_Drift OP Boxman : Unusually nice.
View more comments...